ARIES - Ambrisentan in Patients With Moderate to Severe Pulmonary Arterial Hypertension (PAH)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00091598
Recruitment Status : Completed
First Posted : September 14, 2004
Last Update Posted : March 8, 2010
Information provided by:
Gilead Sciences